Adiponectin - An independent marker of coronary artery disease occurrence rather than a degree of its advancement in comparison to the IMT values in peripheral arteries

Clinica Chimica Acta

Volumn 413, Issue 7-8, 2012, Pages 749-752

  Lisowska, A ^a   Tycinska, A ^a   Knapp, M ^a   Sawicki, R ^a   Lisowski, P ^a   Musial W J ^a   Dobrzycki, S ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adiponectin; Coronary artery disease; Intima media thickness

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTERY; ARTICLE; CARDIOVASCULAR RISK; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN FUNCTION; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

ADIPONECTIN; ADULT; ARTERIES; CORONARY ARTERY DISEASE; HUMANS; MIDDLE AGED; REGRESSION ANALYSIS; ULTRASONOGRAPHY, DOPPLER;

EID: 84857649459     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.006     Document Type: Article

References (27)

1. Miwa R., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981.
2. Spranger J., Kroke A., Möhlig M., et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003, 361:226-228.
3. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
4. Matsuda M., Shimomura I., Sata M., et al. Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 2002, 277:37487-37491.
5. Scherer P., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
6. Pineiro R., Iglesias M., Gallego R., et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005, 579:5163-5169.
7. Krause M.P., Liu Y., Vu V., et al. Adiponectin is expressed by skeletal muscle fibres and influences muscle phenotype and unction. Am J Physiol Cell Physiol 2008, 295:C203-C212.
8. Shinoda Y., Yamaguchi M., Ogata N., et al. Regulation of bone formation by adiponectin through autocrine/paracrine and enocrine pathways. J Cell Biochem 2006, 99:196-208.
9. Kumada M., Kihara S., Sumitsuji S., et al. Osaka CAD Study Group: Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
10. Sattar N., Wannamethee G., Sarwar N., et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006, 114:623-629.
11. Cavusoglu E., Ruwende C., Chopra V., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006, 27:2300-2309.
12. Han S.H., Sakumo I., Shin E.K., Koh K.K. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis 2009, 52:126-140.
13. Dullaart R.P., de Vries R., van Tol A., Sluiter W.J. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 2007, 156:387-394.
14. Lisowska A., Musiał W.J., Prokop J. Clinical implications of ultrasonographic assessment of intima-media thickness in peripheral arteries. Pol Przegl Chir 2003, 4:451-456.
15. Lisowska A., Musiał W.J., Lisowski P., Knapp M., Małyszko J., Dobrzycki S. Intima-media thickness is a useful marker of the extent of coronary artery disease in patients with impaired renal function. Atherosclerosis 2009, 202:470-475.
16. Shibata R., Ouchi N., Murohara T. Adiponectin and cardiovascular disease. Circ J 2009, 73:608-614.
17. Schnabel R., Messow C.M., Lubos E., et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008, 29:649-657.
18. Menon V., Li L., Wang X., Greene T. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006, 17:2599-2606.
19. Iwashima Y., Horio T., Kumada M., et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 2006, 98:1603-1608.
20. Zhang M., Spies C., Ali S., Kanaya A.M., Schiller N.B., Whooley M.A. Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul stud. Atherosclerosis 2009, 205:233-238.
21. Lindsay R.S., Resnick H.E., Zhu J., et al. Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2005, 25:e15-e16.
22. Dullaart R.P., Kappelle P.J. Carotid intima media thickness is associated with plasma adiponectin but not with the leptin: adiponectin ratio independently of metabolic syndrome. Atherosclerosis 2010, 211:393-396.
23. Juonala M., Saarikoski L., Viikari J., et al. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. Atherosclerosis 2011, 217:234-239.
24. Scuteri A., Orru M., Morrell C., et al. Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis 2011, 215:459-464.
25. Wilson S., Sabatine M., Wiviott S., et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial - Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J 2011, 161:1147-1155.
26. Krzyzanowska K., Aso Y., Mittermayer F., Inukai T., Brix J., Schernthaner G. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Transl Res 2009, 153:199-203.
27. Cote M., Cartier A., Reuwer A.Q., et al. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk prospective population study). Am J Cardiol 2011, 108:367-373.